Literature DB >> 27853867

Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients.

Takuro Miyazaki1, Naoya Yamasaki2, Tomoshi Tsuchiya2, Keitaro Matsumoto2, Masaki Kunizaki2, Ryotaro Kamohara2, Go Hatachi2, Ryoichiro Doi2, Tomohiro Obata2, Takeshi Nagayasu2.   

Abstract

PURPOSE: The aim of this retrospective study was to evaluate inflammation-based scoring as a prognostic factor for operable non-small-cell lung cancer (NSCLC) in elderly patients.
METHODS: We collected preoperative data from 108 patients aged above 80 years with NSCLC. Inflammation-based scoring systems, including the C-reactive protein to albumin ratio (CAR) and the Glasgow prognostic score (GPS), as well as other clinicopathological factors, were evaluated as potential prognostic factors.
RESULTS: The median patient age was 82 (range 80-93) years and the 5-year overall and disease-specific survival rates were 49.7 and 73.9%, respectively. The cut-off value for CAR was calculated using a receiver operator characteristics analysis and patients were dichotomized accordingly. Patients with a low CAR had significantly higher overall survival than those with a high CAR (<0.028; 65.2% vs. ≥0.028; 31.0%, respectively; p < 0.01). In univariate analysis, female gender, a low Charlson comorbidity index of 0 or 1 and a low CAR were significantly identified in overall survival. On multivariate analysis, a low CAR (p = 0.03, hazard ratio: 2.13, 95% confidence interval 1.074-4.295) was identified as a significant prognostic factor.
CONCLUSIONS: The preoperative CAR is a useful predictor of overall survival and could be a simple prognostic tool to help identify resectable NSCLC in elderly patients.

Entities:  

Keywords:  C-reactive protein to albumin ratio; Inflammation-based scoring; Lung cancer; Octogenarians; Surgery

Mesh:

Substances:

Year:  2016        PMID: 27853867     DOI: 10.1007/s00595-016-1448-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

Review 1.  The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.

Authors:  Donald C McMillan
Journal:  Cancer Treat Rev       Date:  2012-09-17       Impact factor: 12.111

Review 2.  Risk factors predictive of atrial fibrillation after lung cancer surgery.

Authors:  Takekazu Iwata; Kaoru Nagato; Takahiro Nakajima; Hidemi Suzuki; Shigetoshi Yoshida; Ichiro Yoshino
Journal:  Surg Today       Date:  2015-10-15       Impact factor: 2.549

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Surgical treatment for lung cancer in octogenarians.

Authors:  Masashi Muraoka; Tadayuki Oka; Shinji Akamine; Tsutomu Tagawa; Nobufumi Sasaki; Yasushi Ikuta; Masao Inoue; Takatomo Yamayoshi; Satoshi Hashizume; Yutaka Tagawa; Takeshi Nagayasu
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

5.  A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.

Authors:  Hiroki Saito; Takehiro Noji; Keisuke Okamura; Takahiro Tsuchikawa; Toshiaki Shichinohe; Satoshi Hirano
Journal:  Surgery       Date:  2015-12-10       Impact factor: 3.982

6.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

7.  Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery.

Authors:  Mitsuaki Kawashima; Tomohiro Murakawa; Tomohiro Shinozaki; Junji Ichinose; Haruaki Hino; Chihiro Konoeda; Takehiro Tsuchiya; Tomonori Murayama; Kazuhiro Nagayama; Jun-ichi Nitadori; Masaki Anraku; Jun Nakajima
Journal:  Interact Cardiovasc Thorac Surg       Date:  2015-08-12

8.  The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.

Authors:  Akiyoshi Kinoshita; Hiroshi Onoda; Nami Imai; Akira Iwaku; Mutumi Oishi; Ken Tanaka; Nao Fushiya; Kazuhiko Koike; Hirokazu Nishino; Masato Matsushima
Journal:  Ann Surg Oncol       Date:  2014-09-05       Impact factor: 5.344

9.  Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.

Authors:  Mitsuru Ishizuka; Hitoshi Nagata; Kazutoshi Takagi; Yoshimi Iwasaki; Norisuke Shibuya; Keiichi Kubota
Journal:  Ann Surg Oncol       Date:  2015-11-03       Impact factor: 5.344

10.  Prognostic value of PLR in various cancers: a meta-analysis.

Authors:  Xin Zhou; Yiping Du; Zebo Huang; Jun Xu; Tianzhu Qiu; Jian Wang; Tongshan Wang; Wei Zhu; Ping Liu
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

View more
  13 in total

1.  Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.

Authors:  Takuro Miyazaki; Naoya Yamasaki; Tomoshi Tsuchiya; Keitaro Matsumoto; Ryotaro Kamohara; Go Hatachi; Takeshi Nagayasu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-01-23       Impact factor: 1.520

2.  Clinical significance of the C-reactive protein-to-albumin ratio for the prognosis of patients with esophageal squamous cell carcinoma.

Authors:  Masaki Kunizaki; Tetsuro Tominaga; Kouki Wakata; Takuro Miyazaki; Keitaro Matsumoto; Yorihisa Sumida; Shigekazu Hidaka; Takuya Yamasaki; Toru Yasutake; Terumitu Sawai; Ryuji Hamamoto; Atsushi Nanashima; Takeshi Nagayasu
Journal:  Mol Clin Oncol       Date:  2017-12-08

3.  The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303.

Authors:  Takuro Miyazaki; Hisashi Saji; Hiroshige Nakamura; Takeshi Nagayasu; Norihito Okumura; Masanori Tsuchida; Makoto Sonobe; Keiju Aokage; Masayuki Nakao; Tomohiro Haruki; Morihito Okada; Kenji Suzuki; Masayuki Chida; Ichiro Yoshino
Journal:  Surg Today       Date:  2022-02-24       Impact factor: 2.540

4.  Comparative Analysis of Immunoinflammatory and Nutritional Measures in Surgically Resected Esophageal Cancer: A Single-center Retrospective Study.

Authors:  Makoto Sakai; Makoto Sohda; Hideyuki Saito; Yasunari Ubukata; Nobuhiro Nakazawa; Kengo Kuriyama; Keigo Hara; Akihiko Sano; Kyoichi Ogata; Takehiko Yokobori; Ken Shirabe; Hiroshi Saeki
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

5.  Prognostic impact of C-reactive protein-albumin ratio for the lethality in castration-resistant prostate cancer.

Authors:  Taizo Uchimoto; Kazumasa Komura; Yuya Fujiwara; Kenkichi Saito; Naoki Tanda; Tomohisa Matsunaga; Atsushi Ichihashi; Takeshi Tsutsumi; Takuya Tsujino; Yuki Yoshikawa; Yudai Nishimoto; Tomoaki Takai; Koichiro Minami; Kohei Taniguchi; Tomohito Tanaka; Hirofumi Uehara; Hajime Hirano; Hayahito Nomi; Naokazu Ibuki; Kiyoshi Takahara; Teruo Inamoto; Haruhito Azuma
Journal:  Med Oncol       Date:  2019-11-21       Impact factor: 3.064

6.  Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy.

Authors:  Young W Koh; Hyun W Lee
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

Review 7.  The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.

Authors:  Hong-Jun Xu; Yan Ma; Fang Deng; Wen-Bo Ju; Xin-Yi Sun; Hua Wang
Journal:  Onco Targets Ther       Date:  2017-06-19       Impact factor: 4.147

8.  Lung cancer surgery in HIV-infected patients: An analysis of postoperative complications and long-term survival.

Authors:  Lin Wang; Yongfang Chen; Yifei Wang; Jianjian Liu; Zilu Wen; Hui Chen; Yijun Zhu; Jun Wang; Laiyi Wan; Feng Li; Yanzheng Song
Journal:  Thorac Cancer       Date:  2020-07-05       Impact factor: 3.500

9.  Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study.

Authors:  Jin-Rong Yang; Jia-Ying Xu; Guo-Chong Chen; Na Yu; Jing Yang; Da-Xiong Zeng; Min-Jing Gu; Da-Peng Li; Yu-Song Zhang; Li-Qiang Qin
Journal:  Sci Rep       Date:  2019-05-31       Impact factor: 4.379

10.  Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.

Authors:  Taichi Matsubara; Shinkichi Takamori; Naoki Haratake; Takatoshi Fujishita; Ryo Toyozawa; Kensaku Ito; Mototsugu Shimokawa; Masafumi Yamaguchi; Takashi Seto; Tatsuro Okamoto
Journal:  Ann Surg Oncol       Date:  2020-10-21       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.